The prognosis of lipid reprogramming with the HMG-CoA reductase inhibitor, rosuvastatin, in castrated Egyptian prostate cancer patients: Randomized trial

• Riham M. Karkeet ,

  Roles Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – original draft, Writing – review & editing

  * E-mail: riham.karkeet@nci.cu.edu.eg

  Affiliation Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt

  https://orcid.org/0000-0002-8779-8937

  ⨯
• Abdelrahman N. Zekri,

  Roles Conceptualization, Resources, Supervision, Validation, Visualization, Writing – review & editing

  Affiliation Virology and Immunology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt

  ⨯
• Mohamed M. Sayed-Ahmed,

  Roles Formal analysis, Supervision, Validation, Visualization, Writing – review & editing

  Affiliation Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt

  ⨯
• Ghada M. Sherif,

  Roles Data curation, Formal analysis, Software, Supervision, Validation

  Affiliation Biostatistics and Cancer Epidemiology Department, National Cancer Institute, Cairo University, Cairo, Egypt

  ⨯
• Salem E. Salem,

  Roles Investigation, Validation, Visualization, Writing – review & editing

  Affiliation Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt

  ⨯
• Ahmed Abdelbary,

  Roles Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliation Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt

  ⨯
• Mariam A. Fouad,

  Roles Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Writing – review & editing

  Affiliations Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt, Moleculat Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, United States of America

  ⨯
• Sherif Y. Saad

  Roles Conceptualization, Supervision, Visualization

  Affiliation Pharmacology and Experimental Oncology Unit, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt

  ⨯